case_images: PMC10825037_01
case_images: MRI images of the spinal cord both before and after therapy (A,C,D,F). Gadolinium-enhanced axial T1-weighted MRI of the spinal cord (B,E). MRI of the brain (G-J) revealed the absence of brain lesions. The sagittal T1-weighted image (A) and axial T1-weighted image (D) of the thoracic spinal cord before therapy revealed an abnormal signal in the thoracic and lumbar spinal cord (T11-L1). We did not observe obvious enhancement of spinal lesion in enhanced T1-weighted MRI (B,E). After therapy, the sagittal T1-weighted image (C) and axial T1-weighted image (F) demonstrated a significant reduction in the size of the previously observed lesions.
case_images: fneur-14-1288546-g001.jpg
case_images: PMC10825037_01_fneur-14-1288546-g001.jpg
case_images: fig1
case_images: T1-weighted MRI (Figures 1A,B,D,E). The spinal cord MRI did not indicate any manifestations of acute disseminated encephalomyelitis (ADEM) or multiple sclerosis (MS). Follow-up MRI of the spinal cord revealed evidence of lesion improvement (Figures 1C,F).
case_images: MRI images of the cervical spinal cord (A-C) were obtained. These included sagittal T1-weighted (A), T2-weighted (B), and axial T1-weighted (C) images. Notably, no lesions were observed in the cervical spinal cord.
case_images: fneur-14-1288546-g002.jpg
case_images: PMC10825037_01_fneur-14-1288546-g002.jpg
case_images: fig2
case_images: MRI of the spinal cord revealed no lesions in the cervical spinal cord (Figure 2).